4//SEC Filing
OLSON LAURIE J 4
Accession 0000950170-23-031696
CIK 0001771917other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:49 PM ET
Size
10.3 KB
Accession
0000950170-23-031696
Insider Transaction Report
Form 4
OLSON LAURIE J
Director
Transactions
- Sale
Common Stock
2023-07-03$216.03/sh−400$86,412→ 990 total - Exercise/Conversion
Common Stock
2023-07-03$84.86/sh+1,000$84,860→ 1,990 total - Sale
Common Stock
2023-07-03$215.40/sh−600$129,240→ 1,390 total - Exercise/Conversion
Option (right to buy)
2023-07-03−1,000→ 13,000 totalExercise: $84.86Exp: 2030-08-11→ Common Stock (1,000 underlying)
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.70 to $215.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) through (3) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.70 to $216.43, inclusive.
- [F4]This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020.
Documents
Issuer
Karuna Therapeutics, Inc.
CIK 0001771917
Entity typeother
Related Parties
1- filerCIK 0001553231
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 4:49 PM ET
- Size
- 10.3 KB